Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

Autoimmune hepatitis quietly damages the liver for years before symptoms appear; specialists in Kenya warn of late diagnoses and urge early medical checks. [File, Standard] When people think about ...

When most people think about liver disease, they think about alcohol or hepatitis. What many don’t realize is that the most common cause of chronic liver disease in the United States today has nothing ...

The World Health Organization (WHO) released landmark Consolidated guidance and implementation handbook on hepatitis B and C, ...

James Kang moved to Milpitas from South Korea in his early 20s with his parents and younger sibling, to a diverse community that included Korean churches, grocers, restaurants, media and traditional ...

Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and hepatocellular cancer (HCC, liver cancer). It affects approximately 296 million ...

Autoimmune hepatitis (AIH) is a complex, chronic inflammatory liver disorder in which the body's immune system aberrantly targets hepatocytes, leading to progressive hepatic injury. Characterised by ...

Hepatitis B is one of the most widespread viral infections in the world, with hundreds of millions of people living with it today. Caused by the hepatitis B virus (HBV), this condition primarily ...

A research team from Bochum and Hannover shows that the hepatitis E virus also attacks organs other than the liver. The hepatitis E virus (HEV) causes severe liver inflammation. A research team from ...

As we mark World Hepatitis Day, WHO calls on governments and partners to urgently accelerate efforts to eliminate viral hepatitis as a public health threat and reduce liver cancer deaths. Every 30 ...

BARCELONA, Spain — In a surprising number of patients with hepatitis C and cirrhosis, hepatocellular carcinoma develops within weeks of starting treatment with direct-acting antivirals, new research ...